Jordi Duran Castells, PhD
Adjunct Professor
+34932672000
RESEARCH LINES
- Pathological mechanisms of Lafora disease
- Role of excessive glycogen accumulation in neurodegenerative diseases
- Energy metabolism in the functioning of the nervous system
- Non-canonical roles of glycogen metabolism
MEMBER OF:
School of Engineering
Biological and Biotechnological Chemistry
Its activity focuses on the identification and molecular analysis of proteins and enzymes as therapeutic targets, together with the design and application of enzymes in biocatalysis and biotechnology with microorganisms.
LATEST PROJECTS
NanoLaf (Use of mRNA-loaded polymeric nanoparticles as an innovative replacement therapy to treat Lafora Disease)
Polymeric nanoparticles to deliver mRNA as replacement therapy in Lafora Disease
Funding Agency:
Research Group Link:
Biological and Biotechnological Chemistry (GQBB)
Lafora Disease (Enfermedades neurodegenerativas)
Papel fisiológico y patológico del glucógeno cerebral
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
Chelsea’s Hope (Neurodegeneracion Lafora)
Role específico de astrocitos y neuronase en la enfermedad de Lafora.
Funding Agency:
Research Group Link:
Materials Engineering (GEMAT)
Chemical & Synthetic Biology for Biotherapies (ChemSynBio)
LINKED NEWS
Research
A Gene Therapy for Lafora Disease
13/09/2023
Dr Jordi Duran has recently obtained funding from the Ramón Areces Foundation to find an innovative gene therapy for Lafora disease, a rare disease that currently has no treatment.
READ FULL NEW
7 Questions for...
Jordi Duran
24/11/2021
Dr. Jordi Duran Castells, professor with the Department of Bioengineering and researcher at the IQS School of Engineering
READ FULL NEW
Research
IQS Receives Funding from Chelsea’s Hope for Lafora Disease Research
21/10/2021
The Lafora disease patients association "Chelsea's Hope Lafora Children Research Fund" has just granted Dr Jordi Duran, Professor of Bioengineering at IQS, new funding for his research on this rare neurodegenerative disease.
READ FULL NEW
